Exploring the Causal Relationship Between Coagulation Function and Gestational Diabetes Mellitus Through Mendelian Randomization

ZENG Fanying, SHEN Ping, GUO Weijie, HE Guolin

Abstract

To explore the causal association between coagulation function, including von Willebrand factor (vWF), a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13 (ADAMTS13), activated partial thromboplastin time (aPTT), coagulation factor Ⅷ (FⅧ), coagulation factor Ⅺ (FⅪ), coagulation factor Ⅶ (FⅦ), coagulation factor Ⅹ (FⅩ), endogenous thrombin potential (ETP), plasminogen activator inhibitor-1 (PAI-1), protein C, and plasmin, and gestational diabetes mellitus (GDM) using two-sample two-way Mendelian randomization (MR), and to provide genetic evidence for the association between coagulation function and the pathogenesis of GDM.
Methods The IEU OpenGWAS database was accessed using the R package TwoSampleMR (v 0.5.6) to obtain the statistical data of the genome-wide association study (GWAS) summary of GDM. MR analysis of the causal association between 11 coagulation function and GDM was performed by the inverse-variance weighted method (IVW), the MR-Egger method, and the weighted median method (WM).
Results In this study, the GWAS summary statistics of GDM (covering 5 687 cases and 117 892 controls) were used for MR analysis. It was found that there was a causal relationship between the predicted plasma FⅧ level and the risk for GDM (IVW: [odds ratio, OR]=0.28, 95% confidence interval [CI]: 0.10-0.75, P<0.001; WM: OR=0.30, 95% CI: 0.09-0.98, P<0.001). There was no causal relationship between other coagulation function and the risk for GDM (P>0.05).
Conclusion There is a significant causal relationship between the plasma FⅧ level and the risk for GDM. This finding highlights the complex interaction between coagulation function and glucose metabolism during pregnancy, but further research on this finding is warranted.

 

Keywords: Mendelian randomization, Coagulation factors, Gestational diabetes mellitus

 

Full Text:

PDF


References


CHEN L, MAGLIANO D J, ZIMMET P Z. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol, 2011, 8(4): 228–236. doi: 10.1038/nrendo.2011.183.

ZHU Y, ZHANG C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diabetes Rep, 2016, 16(1): 7. doi: 10.1007/s11892-015-0699-x.

KIM H Y, KIM J, NOH E, et al. Prepregnancy hemoglobin levels and gestational diabetes mellitus in pregnancy. Diabetetes Res Clin Pr, 2021, 171(1): 108608. doi: 10.1016/j.diabres.2020.108608.

LI H, SHEN L, SONG L, et al. Early age at menarche and gestational diabetes mellitus risk: results from the healthy baby cohort study. Rev Rort Endocrinol, 2017, 43(3): 248–252. doi: 10.1016/j.diabet.2017.01.002.

CHOUDHURY A A, DEVI RAJESWARI V. Gestational diabetes mellitus -a metabolic and reproductive disorder. Biomed Pharmacother, 2021, 143(1): 112183. doi: 10.1016/j.biopha.2021.112183.

SHEN Z, YANG C, ZHU P, et al. Protective effects of syringin against oxidative stress and inflammation in diabetic pregnant rats via TLR4/MyD88/NF-κB signaling pathway. Biomed Pharmacother, 2020, 131(1): 110681. doi: 10.1016/j.biopha.2020.110681.

KATRA P, DEREKE J, NILSSON C, et al. Plasma levels of the interleukin-1-receptor antagonist are lower in women with gestational diabetes mellitus and are particularly associated with postpartum development of type 2 diabetes. PLoS One, 2016, 11(5): e0155701. doi: 10.1371/journal. pone.0155701.

DELANEROLLE G, PHIRI P, ZENG Y, et al. A systematic review and meta-analysis of gestational diabetes mellitus and mental health among BAME populations. E Clinical Medicine, 2021, 38(1): 101016. doi: 10. 1016/j.eclinm.2021.101016.

KANG L, LI H Y, OU H Y, et al. Role of placental fibrinogen-like protein 1 in gestational diabetes. Transl Res, 2020, 218(1): 73–80. doi: 10.1016/j. trsl.2020.01.001.

TELIGA-CZAJKOWSKA J, SIENKO J, ZAREBA-SZCZUDLIK J, et al. Influence of glycemic control on coagulation and lipid metabolism in pregnancies complicated by pregestational and gestational diabetes mellitus. Adv Exp Med Biol, 2019, 1176(1): 81–88. doi: 10.1007/ 5584_2019_382.

SOUSA GOMES M, GUIMARãES M, MONTENEGRO N. Thrombolysis in pregnancy: a literature review. J Matern Fetal Neonatal Med, 2019, 32(14): 2418–2428. doi: 10.1080/14767058.2018.1434141.

ZHU Y, LIU Z, MIAO C, et al. Trajectories of maternal D-dimer are associated with the risk of developing adverse maternal and perinatal outcomes: a prospective birth cohort study. Clin Chim Acta, 2023, 543(1): 117324. doi: 10.1016/j.cca.2023.117324.

LIU Y, SUN X, TAO J, et al. Gestational diabetes mellitus is associated with antenatal hypercoagulability and hyperfibrinolysis: a case control study of Chinese women. J Matern Fetal Neonatal Med, 2022, 35(15): 2995–2998. doi: 10.1080/14767058.2020.1818202.

SKRIVANKOVA V W, RICHMOND R C, WOOLF B A R, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA, 2021, 326(16): 1614–1621. doi: 10.1001/jama.2021.18236.

YU T Q, XU W T, SU Y N, et al. Basic principles, methods and limitations of Mendelian randomization studies. Chin J Evid Med, 2021, 21(10): 1227–1234. doi: 10.7507/1672-2531.202107008.

GROVER S, DEL GRECO M F, STEIN C M, et al. Mendelian randomization. Methods Mol Biol, 2017, 1666: 581–628. doi: 10.1007/ 978-1-4939-7274-6_29.

VERDUIJIN M, SIEGERINKI B, JAGER K J, et al. Mendelian randomization: use of genetics to enable causal inference in observational studies. Nephrol Dial Transplant, 2010, 25(5): 1394–1398. doi: 10.1093/ndt/gfq098.

HUANG J, SABATER-LLEAL M, ASSELBERGS F W, et al. Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. Blood, 2012, 120(24): 4873–4881. doi: 10.1182/blood-2012-06-436188.

SUHRE K, ARNOLD M, BHAGWAT A M, et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat Commun, 2017, 8(1): 14357. doi: 10.1038/ncomms14357.

ROCANIN-ARJO A, COHEN W, CARCAILLON L, et al. A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential. Blood, 2014, 123(5): 777–785. doi: 10.1182/blood-2013-10-529628.


Refbacks

  • There are currently no refbacks.